Maya Ilouze

1.9k total citations
41 papers, 1.4k citations indexed

About

Maya Ilouze is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Maya Ilouze has authored 41 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Pulmonary and Respiratory Medicine and 11 papers in Cancer Research. Recurrent topics in Maya Ilouze's work include Lung Cancer Treatments and Mutations (12 papers), Advanced Chemical Sensor Technologies (9 papers) and Animal Virus Infections Studies (8 papers). Maya Ilouze is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), Advanced Chemical Sensor Technologies (9 papers) and Animal Virus Infections Studies (8 papers). Maya Ilouze collaborates with scholars based in Israel, United States and Spain. Maya Ilouze's co-authors include Moshe Kotler, Nir Peled, Arnon Dishon, Maya Davidovich, Hossam Haick, Ayana Perelberg, Lior Soussan‐Gutman, Dekel Shlomi, Fred R. Hirsch and Addie Dvir and has published in prestigious journals such as Journal of Clinical Oncology, Applied and Environmental Microbiology and Cancer Research.

In The Last Decade

Maya Ilouze

40 papers receiving 1.4k citations

Peers

Maya Ilouze

PRM

IMMUN

ONCOL

Robert W. Siegel United States

Weining Wu China

Richard G. Ivey United States

Liyan Cao China

Oliberto Sánchez Chile

William J.J. Finlay United States

Christine Häfner Austria

Zhongfeng Ye United States

Evan P. Booy Canada

Ernesto Rodríguez Netherlands

Robert W. Siegel United States

Maya Ilouze

51 ×0.1

PRM

313 ×0.8

IMMUN

209 ×0.6

ONCOL

87 ×0.3

1.3k ×4.2

Citations per year, relative to Maya Ilouze Maya Ilouze (= 1×) peers Robert W. Siegel

Countries citing papers authored by Maya Ilouze

Since Specialization

Citations

This map shows the geographic impact of Maya Ilouze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maya Ilouze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maya Ilouze more than expected).

Fields of papers citing papers by Maya Ilouze

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maya Ilouze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maya Ilouze. The network helps show where Maya Ilouze may publish in the future.

Co-authorship network of co-authors of Maya Ilouze

This figure shows the co-authorship network connecting the top 25 collaborators of Maya Ilouze. A scholar is included among the top collaborators of Maya Ilouze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maya Ilouze. Maya Ilouze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Roisman, Laila C., et al.. (2018). 145P Impact of next-generation sequencing on survival in lung cancer. Journal of Thoracic Oncology. 13(4). S86–S87. 3 indexed citations

Shlomi, Dekel, Ori Liran, Jair Bar, et al.. (2017). Detection of Lung Cancer and EGFR Mutation by Electronic Nose System. Journal of Thoracic Oncology. 12(10). 1544–1551. 62 indexed citations

Shlomi, Dekel, Ori Liran, Jair Bar, et al.. (2017). MA01.01 Detection of Lung Cancer and EGFR Mutations by Electronic Nose System. Journal of Thoracic Oncology. 12(1). S342–S342. 4 indexed citations

Herbig, Jens, Guy Las, John C. Cancilla, et al.. (2017). Cancer metabolism: the volatile signature of glycolysis— in vitro model in lung cancer cells. Journal of Breath Research. 11(1). 16008–16008. 31 indexed citations

Ilouze, Maya, Laila C. Roisman, Addie Dvir, et al.. (2017). P2.03b-047 The Clinical Impact of Multiplex ctDNA Gene Analysis in Lung Cancer. Journal of Thoracic Oncology. 12(1). S964–S964. 1 indexed citations

Ilouze, Maya, et al.. (2017). PUB137 Lung Cancer in Young Patients: Higher Rate of Driver Mutations, Brain Involvement and Better Survival. Journal of Thoracic Oncology. 12(1). S1526–S1526. 1 indexed citations

Peled, Nir, Laila C. Roisman, Benjamin Miron, et al.. (2017). Subclonal Therapy by Two EGFR TKIs Guided by Sequential Plasma Cell-free DNA in EGFR -Mutated Lung Cancer. Journal of Thoracic Oncology. 12(7). e81–e84. 40 indexed citations

Agmon, Inbar Nardi, Ori Liran, Maya Ilouze, et al.. (2016). Exhaled Breath Analysis for Monitoring Response to Treatment in Advanced Lung Cancer. Journal of Thoracic Oncology. 11(6). 827–837. 100 indexed citations

Ilouze, Maya, et al.. (2015). Mitochondrial induction as a potential radio-sensitizer in lung cancer cells - a short report. Cellular Oncology. 38(3). 247–252. 13 indexed citations

10.

Davies, Michael P.A., Orna Barash, Raneen Jeries, et al.. (2014). Unique volatolomic signatures of TP53 and KRAS in lung cells. British Journal of Cancer. 111(6). 1213–1221. 38 indexed citations

11.

Peled, Nir, Murry W. Wynes, Norihiko Ikeda, et al.. (2013). Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer. Cellular Oncology. 36(4). 277–288. 74 indexed citations

12.

Peled, Nir, Leor Zach, Ori Liran, et al.. (2013). Effective Crizotinib Schedule for Brain Metastases in ALK Rearrangement Metastatic Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 8(12). e112–e113. 25 indexed citations

13.

Peled, Nir, Orna Barash, Ulrike Tisch, et al.. (2013). Volatile fingerprints of cancer specific genetic mutations. Nanomedicine Nanotechnology Biology and Medicine. 9(6). 758–766. 96 indexed citations

14.

Ilouze, Maya, Arnon Dishon, & Moshe Kotler. (2012). Coordinated and sequential transcription of the cyprinid herpesvirus-3 annotated genes. Virus Research. 169(1). 98–106. 35 indexed citations

15.

Peled, Nir, Gary A. Palmer, Fred R. Hirsch, et al.. (2012). Next-Generation Sequencing Identifies and Immunohistochemistry Confirms a Novel Crizotinib-Sensitive ALK Rearrangement in a Patient with Metastatic Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 7(9). e14–e16. 102 indexed citations

16.

Ilouze, Maya, Arnon Dishon, & Moshe Kotler. (2012). Down-regulation of the cyprinid herpesvirus-3 annotated genes in cultured cells maintained at restrictive high temperature. Virus Research. 169(1). 289–295. 14 indexed citations

17.

Perelberg, Ayana, Maya Ilouze, Moshe Kotler, & Michael Steinitz. (2008). Antibody response and resistance of Cyprinus carpio immunized with cyprinid herpes virus 3 (CyHV-3). Vaccine. 26(29-30). 3750–3756. 59 indexed citations

18.

Ilouze, Maya, et al.. (2008). KHV, CNGV or CyHV-3, which is the koi/carp killer?. 6 indexed citations

19.

Ilouze, Maya, Arnon Dishon, Tamar Kahan, & Moshe Kotler. (2006). Cyprinid herpes virus‐3 (CyHV‐3) bears genes of genetically distant large DNA viruses. FEBS Letters. 580(18). 4473–4478. 27 indexed citations

20.

Hutoran, Marina, Ariel Ronen, Ayana Perelberg, et al.. (2005). Description of an as Yet Unclassified DNA Virus from Diseased Cyprinus carpio Species. Journal of Virology. 79(4). 1983–1991. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact